Mingjun Xu

1.7k citations
44 papers · 1.2k · 2 hit papers · h-index 10

Impact in

    • Head and Neck Cancer Studies
  • Oncology top 10%
    • Cancer Immunotherapy and Biomarkers
    • Lung Cancer Research Studies
    • Viral-associated cancers and disorders

Papers in

Mingjun Xu

38 papers receiving 1.1k citations

Mingjun Xu's Hit Papers

Camrelizumab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (CAPTAIN-1st): a multicentre, randomised, double-blind, phase 3 trial 2021 · 330 citations
3300+3+6Years since publication100200300400

Peers

Mingjun Xu
Comparison fields: 5 of 86
  • Otorhinolaryngology 525
  • Oncology 290
  • Cardiology and Cardiovascular Medicine 133
  • Pulmonary and Respiratory Medicine 150
  • Cancer Research 52
Replace Xindong Sun with:
Xindong Sun China
Bob‐Valéry Occéan France
Po‐Ju Lin Taiwan
Raymond Liu Chai United States
Aurora Mirabile Italy
CC Yau Hong Kong
Pingzhang Tang China
Vivian Bongers Netherlands
Mingjun Xu relative to Xindong Sun China Xindong Sun's profile →
Citations per field
00.5×5×11.5×
Xindong Sun · 1×
Citations per year

Countries citing papers authored by Mingjun Xu

Since Specialization
Citations

This map shows the geographic impact of Mingjun Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingjun Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingjun Xu more than expected).

Fields of papers citing papers by Mingjun Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingjun Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingjun Xu. The network helps show where Mingjun Xu may publish in the future.

Co-authors

The 25 scholars most cited alongside Mingjun Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mingjun Xu Line = papers co-authored together Mingjun Xu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial
Hit paper breakdown →
2016423
2
Camrelizumab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (CAPTAIN-1st): a multicentre, randomised, double-blind, phase 3 trial
Hit paper breakdown →
2021330
3 202183
4 201573
5 201941
6 201535
7 202122
8 201620
9 202013
10 202511
11 201910
12 201710
13 20259
14 20169
15 20257
16 20217
17 20256
18 20255
19 20205
20 20195

About Mingjun Xu

Mingjun Xu is a scholar working on Cardiology and Cardiovascular Medicine, Otorhinolaryngology, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Control and Systems Engineering, having authored 44 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cardiovascular Health and Disease Prevention (6 papers), Head and Neck Cancer Studies (5 papers), Magnetic Bearings and Levitation Dynamics (5 papers), Electric Motor Design and Analysis (5 papers), Cardiovascular Function and Risk Factors (4 papers), Cerebrovascular and Carotid Artery Diseases (4 papers), Electrocatalysts for Energy Conversion (2 papers) and Lipid metabolism and disorders (2 papers). The work is most often cited by research in Otorhinolaryngology (525 citations), Oncology (290 citations), Cardiology and Cardiovascular Medicine (133 citations), Pulmonary and Respiratory Medicine (150 citations) and Cancer Research (52 citations). Mingjun Xu has collaborated with scholars based in China, Thailand and Bangladesh. Frequent co-authors include Yun Zhang, Guihua Yao, Mei Zhang, Zhian Li, Ligang Fang, Hong Tang, Yuming Mu, You‐Bin Deng, Yan Deng and Mei Zhang. Their work appears in journals such as European Heart Journal - Cardiovascular Imaging, International Journal of Radiation Oncology*Biology*Physics, Journal of Clinical Oncology, Scientific Reports and Journal of the American Society of Echocardiography.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact